GLAVI(SZ:300900)2026-01-28 10:30Financial Performance - The company expects a net loss of between 60 million and 90 million RMB for the fiscal year 2025, compared to a loss of 49.1 million RMB in the same period last year[4]. - The expected net loss after deducting non-recurring gains and losses is projected to be between 100 million and 130 million RMB, compared to a loss of 55.4 million RMB in the previous year[4]. - The company anticipates that non-recurring gains and losses will impact net profit by approximately 40 million RMB, an increase of about 3.37 million RMB compared to the previous year[10]. - The financial data presented is preliminary and will be detailed in the 2025 annual report, with actual figures subject to audit[11]. Revenue and Profitability - The company's revenue growth has slowed, and gross profit margin has declined due to industry cyclical adjustments and fragmented market demand, impacting profit margins[7]. - The company expects improvements in revenue and gross profit margin as new orders are secured and business layout is enhanced[7]. Financial Management - Financial expenses have significantly increased due to expanded bank borrowings to support core technology R&D and market expansion, alongside limited conversion of the company's convertible bonds[8]. - The company has initiated a mechanism for early redemption of its convertible bonds, which is expected to reduce interest expenses in 2026[8]. Business Strategy - The company is focusing on optimizing its business structure and product matrix, aiming for stable operational development despite short-term pressures[6]. - The company has conducted a comprehensive review and impairment testing of its assets, with impairment amounts to be determined by external evaluators[9].